Role of ornithine decarboxylase in proliferation of prolactin-dependent lymphoma cells.
Mitogenic stimulation of Nb2 lymphoma cells by lactogenic hormones (prolactin, human growth hormone) caused a dramatic early increase in ornithine decarboxylase (ODC) activity that achieved a maximal level by 6-8 h. A marked increase in ODC activity was also generated when cells which had reached a growth plateau were transferred to fresh medium that did not stimulate growth. Furthermore, low concentrations of human growth hormone (20 pg/mL) elicited a proliferative response, but did not cause a detectable early increase in ODC activity. The early peak of ODC activity thus appeared not to be directly involved in mediating lactogen-stimulated growth nor was it required to support the mitogenic response. However, prolonged suppression of ODC activity by DL-alpha-difluoromethylornithine (DFMO) (200 microM) attenuated the growth of Nb2 cells (50-60% inhibition), indicating that normal cell growth was dependent on ODC and polyamine biosynthesis. Under these conditions, putrescine, the enzyme product, or the polyamines spermidine and spermine restored normal cell growth when added at a concentration of 1 microM or greater. Nb2-SP cells, variants which proliferate in the absence of prolactin, were about two times more resistant to the growth suppressive effects of DFMO than prolactin-responsive Nb2 cells.
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D000518:Eflornithine; D013006:Growth Hormone / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008223:Lymphoma / Q000201:enzymology / Q000473:pathology*; D009952:Ornithine / Q000031:analogs & derivatives / Q000494:pharmacology; D009955:Ornithine Decarboxylase / Q000378:metabolism*; D065108:Ornithine Decarboxylase Inhibitors; D011388:Prolactin / Q000494:pharmacology*
D065108:Ornithine Decarboxylase Inhibitors; D011388:Prolactin; D013006:Growth Hormone; D009952:Ornithine; D009955:Ornithine Decarboxylase; D000518:Eflornithine